XEMILOFIBAN, AN ORAL GPIIB IIIA RECEPTOR ANTAGONIST IS ENHANCED BY ASPIRIN IN INHIBITING NEOINTIMAL PROLIFERATION FOLLOWING PERCUTANEOUS CORONARY ANGIOPLASTY/
Jt. Willerson et al., XEMILOFIBAN, AN ORAL GPIIB IIIA RECEPTOR ANTAGONIST IS ENHANCED BY ASPIRIN IN INHIBITING NEOINTIMAL PROLIFERATION FOLLOWING PERCUTANEOUS CORONARY ANGIOPLASTY/, Circulation, 96(8), 1997, pp. 930-930